Published ahead of print on January 26, 2006, doi:10.1164/rccm.200507-1126OC
© 2006 American Thoracic Society doi: 10.1164/rccm.200507-1126OC
Protein Profiles of Bronchoalveolar Lavage Fluid from Patients with Pulmonary SarcoidosisFaculty of Medicine, Palacky University, Olomouc, Czech Republic; Core Unit Chip Application, Institute of Human Genetics and Anthropology, Friedrich Schiller University, Jena, Germany; and Royal Brompton Hospital, London, United Kingdom Correspondence and requests for reprints should be addressed to Martin Petrek, M.D., Palacky University, Medical Faculty, I.P. Pavlova Str. 6, CZ-775 20 Olomouc, Czech Republic. E-mail: petrekm{at}fnol.cz Background: Pulmonary sarcoidosis is a multisystem granulomatous disease with various clinical phenotypes. So far, there has been little information on protein patterns (PPs) of bronchoalveolar lavage fluid (BALF) from patients with sarcoidosis and no data are available on PPs in clinical disease subtypes. Objectives: To investigate the PP of BALF from patients with pulmonary sarcoidosis, to evaluate whether PPs reflect disease course as assessed by chest X-ray (CXR), and to compare PPs between patients with/without Löfgren's syndrome. Methods: Surface-enhanced laser desorption/ionizationtime-of-flight mass spectroscopy was applied to investigate PPs in unconcentrated BALF from 65 patients (CXR stage I, n = 32; CXR stage II, n = 22, CXR stage III, n = 11) and 23 healthy control subjects. The Mann-Whitney U test was used to detect differentially expressed protein peaks. After reversed-phase fractionation, peptide fingerprint mapping and immunodepletion were used to identify deregulated (up-regulated or down-regulated) proteins.
Results: Forty differentially expressed protein entities (2.75185.62 kD) were detected in patients with pulmonary sarcoidosis versus control subjects (p < 0.05). Whereas 13 peaks (33%) were present across all CXR stages, 27 (67%) were specific for particular CXR stages. Comparison of PPs between CXR stage I patients with or without Löfgren's syndrome revealed 25 differentially expressed peaks. The total number of deregulated peaks and also of those associated with sarcoidosis as a whole were markedly lower in patients with Löfgren's syndrome in comparison with other sarcoid phenotypes. Human serum albumin, Conclusion: Surface-enhanced laser desorption/ionizationtime-of-flight mass spectroscopy enables determination of protein patterns in sarcoid BALF and allows detection of protein patterns linked to a particular disease course.
Key Words: albumin This article has been cited by other articles:
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||